000 | 01440 a2200421 4500 | ||
---|---|---|---|
005 | 20250512213354.0 | ||
264 | 0 | _c19840402 | |
008 | 198404s 0 0 eng d | ||
022 | _a0004-4172 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDunzendorfer, U | |
245 | 0 | 0 |
_aSome effects of inhibitors of polyamine synthesis on experimental prostatic cancer. _h[electronic resource] |
260 |
_bArzneimittel-Forschung _c1984 |
||
300 |
_a36-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 |
_aAdenosylmethionine Decarboxylase _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarboxy-Lyases _xantagonists & inhibitors |
650 | 0 | 4 | _aEflornithine |
650 | 0 | 4 |
_aGuanidines _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aMitoguazone _xtherapeutic use |
650 | 0 | 4 |
_aOrnithine _xanalogs & derivatives |
650 | 0 | 4 | _aOrnithine Decarboxylase Inhibitors |
650 | 0 | 4 |
_aPolyamines _xbiosynthesis |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aVidarabine _xtherapeutic use |
700 | 1 | _aReleyea, N | |
700 | 1 | _aWhitmore, W F | |
700 | 1 | _aFogh, J | |
700 | 1 | _aBalis, M E | |
773 | 0 |
_tArzneimittel-Forschung _gvol. 34 _gno. 1 _gp. 36-9 |
|
999 |
_c6422840 _d6422840 |